Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AFJK vs CEPF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CEPF Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 5–1 Matrix Metrics)

CEPF Overall Winner 6-Pillar Tally: AFJK 0 – 4 CEPF (2 Tie) Matrix Metrics: AFJK 1 – 5 CEPF

As of Nov 20, 2026, Cantor Equity Partners IV, Inc. Class A (CEPF) is the stronger overall head-to-head candidate over Aimei Health Technology Co., Ltd (AFJK) in the Tradestie Institutional Equity Comparison Engine, winning 5–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AFJK carries a Unified Composite Score of 48.1/100 (HOLD) at $11.78 (N/M Forward P/E, 0.0% operating margin), whereas CEPF carries 47.6/100 (HOLD) at $10.33 (N/M Forward P/E, 0.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AFJK vs CEPF
AFJK US Equity
Aimei Health Technology Co., Ltd
Blank Checks
$11.78
-1.01% 1D
Market Cap $37.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.96β · 28% Vol
Unified Composite Score
48.1 / 100 HOLD
Tech 62.0 Fund 46.0 Flow 50.0 Mom 35.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.2 · SMA20: $12.13 · SMA50: $12.18
CEPF NASDAQ Head-to-Head Winner
Cantor Equity Partners IV, Inc. Class A Ordinary Shares
Blank Checks
$10.33
+0.1% 1D
Market Cap $589.8M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 2% Vol
Unified Composite Score
47.6 / 100 HOLD
Tech 50.0 Fund 46.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.4 · SMA20: $10.33 · SMA50: $10.31

6-Pillar Scorecard Institutional Category Breakdown (AFJK 0 – 4 CEPF)

Columns: Metric · AFJK · CEPF
1. Valuation Multiples CEPF
Forward P/E N/M N/M
Trailing P/E N/M 30.4x
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale CEPF
Revenue Growth (YoY) +0.0% +0.0%
Earnings Growth (YoY) -43.4% +30.2%
TTM Revenue (USD) N/A N/A
Market Cap $37.7M $589.8M
3. Profitability & Quality CEPF
Gross Margin N/A N/A
Operating Margin 0.0% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) 0.0% 87.3%
4. Balance Sheet & Cash Flow CEPF
Cash Generation (TTM) -$100,091 N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $499,415 Net Debt (0.26x D/E) 87.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Shell Companies Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AFJK (1) vs CEPF (5)
Institutional Metric AFJK CEPF Criterion Row Edge
Market Capitalization
Scale
$37.7M $589.8M Larger Scale CEPF
Trailing P/E Ratio
Valuation
N/M 30.4x Lower Multiple CEPF
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +0.0% Higher Growth Tie
Operating Margin (TTM)
Profitability
0.0% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
0.0% 87.3% Higher ROE CEPF
52-Week Range Position
Momentum
4% ($7–$130) 39% ($10–$11) Stronger Trend CEPF
Beta / 30D Volatility
Risk Regime
0.96β · 28% Vol 0.02β · 2% Vol Lower Realized Risk CEPF
Unified Institutional Score
Composite Signal
48.1 / 100 (HOLD) 47.6 / 100 (HOLD) Higher Composite AFJK
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$100,091 ($499,415 Net Debt (0.26x D/E)) N/A (87.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CEPF +4.68 pp
AFJK: -4.0% · CEPF: +0.68%
3M Horizon CEPF +0.84 pp
AFJK: -1.42% · CEPF: -0.58%
6M Horizon CEPF +75.15 pp
AFJK: -74.37% · CEPF: +0.78%
1Y Horizon CEPF +2.48 pp
AFJK: -3.44% · CEPF: -0.96%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AFJK vs CEPF. Trailing 12-month operating profitability (AFJK 0.0% vs CEPF 0.0%) and valuation multiples (AFJK N/M vs CEPF N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AFJK ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
CEPF ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E87.3% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AFJK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AFJK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CEPF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CEPF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AFJK Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $37.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CEPF Moat Profile High-Margin Pricing Power Moat
Shell Companies Operator
Competes within the Shell Companies value chain with $589.8M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AFJK vs CEPF Key Questions & Quantitative Answers

As of Nov 20, 2026, Cantor Equity Partners IV, Inc. Class A (CEPF) is the stronger overall head-to-head candidate over Aimei Health Technology Co., Ltd (AFJK) in the Tradestie Institutional Equity Comparison Engine, winning 5–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AFJK carries a Unified Composite Score of 48.1/100 (HOLD) at $11.78 (N/M Forward P/E, 0.0% operating margin), whereas CEPF carries 47.6/100 (HOLD) at $10.33 (N/M Forward P/E, 0.0% operating margin). Technically, AFJK sits in a Neutral phase (RSI 41.2, UNCLASSIFIED options structure) and CEPF sits in a Neutral phase (RSI 53.4, UNCLASSIFIED options structure).

CEPF leads the Growth & Scale pillar: AFJK posts +0.0% YoY revenue growth and -43.4% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with CEPF at +0.0% YoY revenue growth and +30.2% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, AFJK generates N/A in USD-normalized revenue versus N/A for CEPF. In operating R&D and SG&A reinvestment, AFJK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CEPF.

CEPF screens cheaper on headline valuation multiples. AFJK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas CEPF trades at N/M Forward P/E, 30.4x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AFJK (0.0% ROE) versus CEPF (87.3% ROE) capital efficiency.

In options market volatility and institutional positioning, AFJK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 28% Vol realized risk). By comparison, CEPF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.